Evogene Balance Sheet
Evogene's total assets for Q1 2026 were $17.95M, a decrease of -10.47% from the previous quarter. EVGN total liabilities were $6.81M for the fiscal quarter, a 36.23% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.